NCT00340262View on ClinicalTrials.gov

Bone Mineral Density and Subsequent Cancer Risk

CompletedOBSERVATIONAL
Enrollment

15,595

Participants

Timeline

Start Date

April 7, 2000

Primary Completion Date

December 31, 2004

Study Completion Date

March 26, 2020

Conditions
Endometrial CancerBreast Cancer
Trial Locations (1)

20892

National Cancer Institute (NCI), 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00340262 - Bone Mineral Density and Subsequent Cancer Risk | Biotech Hunter | Biotech Hunter